Scholar Rock Holding Corporation

DB:2QK Stock Report

Market Cap: €4.1b

Scholar Rock Holding Management

Management criteria checks 3/4

Scholar Rock Holding's CEO is Jay Backstrom, appointed in Oct 2022, has a tenure of 2.17 years. total yearly compensation is $4.11M, comprised of 15.2% salary and 84.8% bonuses, including company stock and options. directly owns 0.028% of the company’s shares, worth €1.13M. The average tenure of the management team and the board of directors is 2.2 years and 7.8 years respectively.

Key information

Jay Backstrom

Chief executive officer

US$4.1m

Total compensation

CEO salary percentage15.2%
CEO tenure2.2yrs
CEO ownership0.03%
Management average tenure2.2yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jay Backstrom's remuneration changed compared to Scholar Rock Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$226m

Jun 30 2024n/an/a

-US$204m

Mar 31 2024n/an/a

-US$183m

Dec 31 2023US$4mUS$624k

-US$166m

Sep 30 2023n/an/a

-US$159m

Jun 30 2023n/an/a

-US$160m

Mar 31 2023n/an/a

-US$166m

Dec 31 2022US$7mUS$159k

-US$135m

Compensation vs Market: Jay's total compensation ($USD4.11M) is above average for companies of similar size in the German market ($USD1.93M).

Compensation vs Earnings: Jay's compensation has been consistent with company performance over the past year.

CEO

Jay Backstrom (69 yo)

2.2yrs

Tenure

US$4,111,853

Compensation

Dr. Jay Thomas Backstrom, M.D., M.P.H., serves as Non-Executive Director of LAVA Therapeutics N.V. since June 2022. He serves as Director at Be Biopharma, Inc. since December 2021. He had served as a Direc...

Leadership Team

NamePositionTenureCompensationOwnership
Jay Backstrom
President2.2yrsUS$4.11m0.028%
€ 1.1m
Edward Myles
CFO, COO & Treasurer4.4yrsUS$2.01m0%
€ 0
Tracey Sacco
Chief Commercial Officer1.8yrsUS$2.28m0%
€ 0
Mo Qatanani
Chief Scientific Officerless than a yearno data0.022%
€ 884.3k
Rushmie Nofsinger
Vice President of Corporate Affairs & Investor Relationsno datano datano data
Junlin Ho
General Counsel & Corporate Secretary4.8yrsUS$2.13m0.079%
€ 3.3m
Caryn Parlavecchio
Chief Human Resources Officer3.3yrsno data0.043%
€ 1.7m
Lisa Price
Senior Vice President of Human Resourcesno datano datano data
Erin Moore
Senior Vice President of Financeno datano datano data
Ryan Iarrobino
Senior Vice President of Clinical Development & Operations4.8yrsno datano data
Jing Marantz
Chief Medical Officer2.1yrsno data0.078%
€ 3.2m
Beth Shafer
Chief Business Officerless than a yearno datano data

2.2yrs

Average Tenure

51.5yo

Average Age

Experienced Management: 2QK's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jay Backstrom
President2.2yrsUS$4.11m0.028%
€ 1.1m
Michael Gilman
Independent Director & Member of Scientific Advisory Board11.1yrsUS$299.20k0.040%
€ 1.6m
Timothy Springer
Member of Scientific Advisory Boardno dataUS$48.97kno data
Jeffrey Flier
Independent Director & Member of Scientific Advisory Board8.2yrsUS$305.70k0.033%
€ 1.4m
Leonard Zon
Member of Scientific Advisory Boardno datano datano data
Daniel Rifkin
Member of Scientific Advisory Boardno datano datano data
Kristina Burow
Independent Director10.3yrsUS$300.34k0.0057%
€ 233.6k
Joan Massague
Member of Scientific Advisory Boardno datano datano data
David Hallal
Independent Chairman of the Board7.4yrsUS$416.70k0.31%
€ 12.7m
Scott L. Friedman
Member of Scientific Advisory Boardno datano datano data
Barry Coller
Member of Scientific Advisory Boardno datano datano data
Joshua Reed
Independent Director3.8yrsUS$305.70k0%
€ 0

7.8yrs

Average Tenure

69yo

Average Age

Experienced Board: 2QK's board of directors are considered experienced (7.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 19:41
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Scholar Rock Holding Corporation is covered by 16 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Etzer DaroutBMO Capital Markets Equity Research
Guyn KimBMO Capital Markets Equity Research